NASOPHARYNX CANCER

Clinical trials for NASOPHARYNX CANCER explained in plain language.

Never miss a new study

Get alerted when new NASOPHARYNX CANCER trials appear

Sign up with your email to follow new studies for NASOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 2

Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment

Disease control Not yet recruiting

This trial tests whether adding the immunotherapy drugs cemiplimab (with or without fianlimab) to standard chemotherapy before chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer. About 60 adults with non-metastatic, EBV-positive nasopharyngeal carc…

Matched conditions: NASOPHARYNX CANCER

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

NASOPHARYNX CANCER

Get alerted when new NASOPHARYNX CANCER trials appear

Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment